Global Sildenafil Market, By Product Type (Branded and Generics), Application (Peripheral Vasodilator and Erectile Dysfunction), End-Users (Clinics, Hospitals, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Sildenafil Market
Sildenafil market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.80% and is expected to reach USD 2,096.19 million by 2028 in the above-mentioned research forecast period. Presence of branded drugs and increasing prevalence of erectile dysfunction worldwide.
Moreover, rising awareness and increasing prevalence of diabetes and obesity also boost up the market growth. Growing geriatric population and rising healthcare expenditure act as an opportunity for market growth. However, side effects caused by drugs and a strict regulatory framework may hamper the global sildenafil market.
Sildenafil is phosphodiesterase inhibitor and is indicated for the treatment of erectile dysfunction in men. This medicine improves the exercise ability in adults suffering from pulmonary arterial hypertension. It treats erectile dysfunction by enhancing the blood flow to the penis during sexual stimulation. This increase in blood flow leads to an erection. Sildenafil works by relaxing the blood vessels of lungs, which allows easy blood flow.
As per the studies conducted, this has been reported that erectile dysfunction is highly prevalent with 3-76.5% prevalence rate and it increases with an increase in age. This affected population is hugely dependent upon sildenafil to achieve better treatment, hence providing lucrative growth.
This sildenafil market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Sildenafil Market Scope and Market Size
Sildenafil market is segmented on the basis of product type, application, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the sildenafil market is segmented into branded and generics.
- On the basis of application, the sildenafil market is segmented into peripheral vasodilator and erectile dysfunction.
- On the basis of end-users, the sildenafil market is segmented into clinics, hospitals, and others.
- On the basis of distribution channel, the sildenafil market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Sildenafil Market Country Level Analysis
Sildenafil market is analysed and market size information is provided by country, product type, application, end-users and distribution channe as referenced above.
The countries covered in the sildenafil market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts for the largest market share due to branded drugs and high acceptance of well-recognized drugs. Europe is also expected to grow exponentially due to an established healthcare and research and development activities. Asia-Pacific is expected to account for the largest market share due to rising prevalence of erectile dysfunction causing infections, growing geriatric population, increasing government initiatives for growth of pharmaceutical industries.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Sildenafil market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Sildenafil Market Share Analysis
Sildenafil market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Sildenafil market.
The major players covered in the sildenafil market are Pfizer Inc., Century Pharmaceuticals Ltd., Polpharma, Deva Holdings, Actavis, Inc., Accord-UK Ltd., Mantra Pharma, ANGITA, Apotex Inc., Bayer AG, Ritz Formulations Pvt. Ltd., Cipla, Abbott, Viatris Inc., Sandoz, Hetero Healthcare Limited, Delphis Pharma, Teva Pharmaceuticals USA, Inc., Lupin Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC., Umang Pharmaceuticals among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-